Ipromati-i-CRM 2 / Ceramide 2

Inkcazo emfutshane:

I-analog ye-lipophilic ye-lipophilic ye-lipophilic. Unesakhiwo esifanayo nesixhobo esibonisa i-scuticle yesikhumba, inokuthi ichithe isikhumba ngokukhawuleza, idibanise amanzi ukwenza isakhiwo se-reticular kunye nokutsala umswakama, inokuthi isuse i-rackas. Inokomeleza amandla okubambisa iiseli ze-epidermic, ukulungisa nokubuyisela umsebenzi wesikrini se-dermal ke ukunciphisa uphawu lokungafuneki, kunye nokuphucula i-outvicel yokubuyisela kwimeko yesiqhelo. Iphepha ukuthintela okanye inciphise i-epidermition ekhutshwe yi-ultra violetion i-ray ray i-rays iluncedo kwi-Derm Anting.


Iinkcukacha zemveliso

Iimpawu zeMveliso

Igama lebrand Ipromacare-CRM 2
I-CASS No. I-100403-19-8-8-8
IGAMA I-Ceramide 2
Isicelo Toner; Ilogo yokufuma; Iintsuma; Imaski; I-canocy yobuso
Iphakheji I-1kg Net ibhegi nganye
Imbonakalo Ipowder emhlophe
I-assay I-95.0% min
Ukunyibilikisa Inyibilikhi yeoyile
Umsebenzi Iiarhente zokunyibilika
Beka ubomi kwishelufa iminyaka eyi-2
Ukugcinwa Gcina isikhongozeli sivaliwe ngokuqinileyo kwaye kwindawo epholileyo. Hlala kude nobushushu.
Idosi Ukuya kwi-0.1-0.5% (impumelelo evunyiweyo iku-2%).

Isicelo

I-Cemiramide yi-Cespheton ye-Phospholipid i-Cespholifi, i-Cesmide Ethanolamine, i-phoneround etrola iqulathe i-Cebrane, i-Cesmide yeyona ndawo iphambili ye-tractlix, ekugcineni i-stneum corneum Ibhalansi yokufuma idlala indima ebalulekileyo.Chramide inamandla amakhulu okunxibelelanisa iimolekyuli zamanzi, igcina umswakama wesikhumba ngokwenza inethiwekhi kwi-straneum conneum.

I-Ceramide 2 isetyenziswa njengolusu, i-antioxidant kunye ne-moistursider kwi-cosmetics, inokuphucula ukusebenza kwe-sebum kwaye ilungele i-oyile ye-cebaraous ye-cebaraous ifana ne-oyile kunye ne-oyile ye-oyile kunye ne-oyile inesithambiso inesithambiso Ukuvula isithako kwi-stroneum corneum, enokomeleza isithintelo solusu kunye nolusu lokwakha izilolo ezinokuphumeza iimveliso ze-ceramides kunokunciphisa ukulungiswa kunye nokulahleka kwamanzi, ukomeleza isithintelo samanzi.


  • Ngaphambili:
  • Okulandelayo: